Literature DB >> 22123823

Competitive interactions of cancer cells and normal cells via secretory microRNAs.

Nobuyoshi Kosaka1, Haruhisa Iguchi, Yusuke Yoshioka, Keitaro Hagiwara, Fumitaka Takeshita, Takahiro Ochiya.   

Abstract

Normal epithelial cells regulate the secretion of autocrine and paracrine factors that prevent aberrant growth of neighboring cells, leading to healthy development and normal metabolism. One reason for tumor initiation is considered to be a failure of this homeostatic cell competitive system. Here we identify tumor-suppressive microRNAs (miRNAs) secreted by normal cells as anti-proliferative signal entities. Culture supernatant of normal epithelial prostate PNT-2 cells attenuated proliferation of PC-3M-luc cells, prostate cancer cells. Global analysis of miRNA expression signature revealed that a variety of tumor-suppressive miRNAs are released from PNT-2 cells. Of these miRNAs, secretory miR-143 could induce growth inhibition exclusively in cancer cells in vitro and in vivo. These results suggest that secretory tumor-suppressive miRNAs can act as a death signal in a cell competitive process. This study provides a novel insight into a tumor initiation mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123823      PMCID: PMC3256909          DOI: 10.1074/jbc.M111.288662

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  The microRNA pathway and cancer.

Authors:  Pieter Bas Kwak; Shintaro Iwasaki; Yukihide Tomari
Journal:  Cancer Sci       Date:  2010-11       Impact factor: 6.716

2.  Secretory mechanisms and intercellular transfer of microRNAs in living cells.

Authors:  Nobuyoshi Kosaka; Haruhisa Iguchi; Yusuke Yoshioka; Fumitaka Takeshita; Yasushi Matsuki; Takahiro Ochiya
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

3.  p53-mediated hematopoietic stem and progenitor cell competition.

Authors:  Tanya Bondar; Ruslan Medzhitov
Journal:  Cell Stem Cell       Date:  2010-04-02       Impact factor: 24.633

4.  MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression.

Authors:  Yasunori Fujita; Keitaro Kojima; Riyako Ohhashi; Nanako Hamada; Yoshinori Nozawa; Aya Kitamoto; Akira Sato; Shinji Kondo; Toshio Kojima; Takashi Deguchi; Masafumi Ito
Journal:  J Biol Chem       Date:  2010-04-20       Impact factor: 5.157

5.  Functional delivery of viral miRNAs via exosomes.

Authors:  D Michiel Pegtel; Katherine Cosmopoulos; David A Thorley-Lawson; Monique A J van Eijndhoven; Erik S Hopmans; Jelle L Lindenberg; Tanja D de Gruijl; Thomas Würdinger; Jaap M Middeldorp
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-18       Impact factor: 11.205

6.  Stromal endothelial cells directly influence cancer progression.

Authors:  Joseph W Franses; Aaron B Baker; Vipul C Chitalia; Elazer R Edelman
Journal:  Sci Transl Med       Date:  2011-01-19       Impact factor: 17.956

7.  miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.

Authors:  Hanna E Rauhala; Sanni E Jalava; Jarkko Isotalo; Hazel Bracken; Saara Lehmusvaara; Teuvo L J Tammela; Hannu Oja; Tapio Visakorpi
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

8.  The exosome pathway in K562 cells is regulated by Rab11.

Authors:  Ariel Savina; Michel Vidal; Maria I Colombo
Journal:  J Cell Sci       Date:  2002-06-15       Impact factor: 5.285

9.  Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT.

Authors:  Xinsheng Peng; Wei Guo; Tiejian Liu; Xi Wang; Xiang'an Tu; Dafu Xiong; Song Chen; Yingrong Lai; Hong Du; Guangfu Chen; Guanglin Liu; Yubo Tang; Shuai Huang; Xuenong Zou
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

10.  miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.

Authors:  Cyrielle Clapé; Vanessa Fritz; Corinne Henriquet; Florence Apparailly; Pedro Luis Fernandez; François Iborra; Christophe Avancès; Martin Villalba; Stéphane Culine; Lluis Fajas
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

View more
  114 in total

1.  First principles of Hamiltonian medicine.

Authors:  Bernard Crespi; Kevin Foster; Francisco Úbeda
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-03-31       Impact factor: 6.237

2.  Disease-on-a-chip: mimicry of tumor growth in mammary ducts.

Authors:  Pierre-Alexandre Vidi; Teimour Maleki; Manuel Ochoa; Lei Wang; Sara M Clark; James F Leary; Sophie A Lelièvre
Journal:  Lab Chip       Date:  2013-11-08       Impact factor: 6.799

Review 3.  Exosomes and their Application in Biomedical Field: Difficulties and Advantages.

Authors:  Jafar Rezaie; Saeed Ajezi; Çığır Biray Avci; Mohammad Karimipour; Mohammad Hossein Geranmayeh; Alireza Nourazarian; Emel Sokullu; Aysa Rezabakhsh; Reza Rahbarghazi
Journal:  Mol Neurobiol       Date:  2017-05-11       Impact factor: 5.590

Review 4.  MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases.

Authors:  Akiko Matsuda; Irene K Yan; Catherine Foye; Mansi Parasramka; Tushar Patel
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2016-08-01       Impact factor: 4.690

Review 5.  Extracellular RNA mediates and marks cancer progression.

Authors:  Jasmina S Redzic; Leonora Balaj; Kristan E van der Vos; Xandra O Breakefield
Journal:  Semin Cancer Biol       Date:  2014-04-28       Impact factor: 15.707

6.  Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing.

Authors:  Marie-Cécile Didiot; Lauren M Hall; Andrew H Coles; Reka A Haraszti; Bruno Mdc Godinho; Kathryn Chase; Ellen Sapp; Socheata Ly; Julia F Alterman; Matthew R Hassler; Dimas Echeverria; Lakshmi Raj; David V Morrissey; Marian DiFiglia; Neil Aronin; Anastasia Khvorova
Journal:  Mol Ther       Date:  2016-06-27       Impact factor: 11.454

7.  Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.

Authors:  Tomohiro Umezu; Satoshi Imanishi; Kenko Azuma; Chiaki Kobayashi; Seiichiro Yoshizawa; Kazuma Ohyashiki; Junko H Ohyashiki
Journal:  Blood Adv       Date:  2017-05-16

Review 8.  Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.

Authors:  Bruna Scaggiante; Maryam Kazemi; Gabriele Pozzato; Barbara Dapas; Rosella Farra; Mario Grassi; Fabrizio Zanconati; Gabriele Grassi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 9.  Versatile roles of extracellular vesicles in cancer.

Authors:  Nobuyoshi Kosaka; Yusuke Yoshioka; Yu Fujita; Takahiro Ochiya
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

10.  Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism.

Authors:  Claudia Arenaccio; Chiara Chiozzini; Sandra Columba-Cabezas; Francesco Manfredi; Elisabetta Affabris; Andreas Baur; Maurizio Federico
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.